Pro Medicus Limited (ASX:PME) is a Melbourne-based software owner and developer, licensing products to large US hospitals and Australian radiology clinics. The company has offices in Richmond, Victoria, Berlin, Germany and in the United States.
The CSL Ltd (ASX:CSL) share price is up 6.8% since the start of 2024. It’s probably worth asking, ‘is the CSL share price undervalued?’
The Pro Medicus Limited (ASX:PME) share price is up 53.5% since the start of 2024. It’s probably worth asking, ‘is the PME share price undervalued?’
The CSL Ltd (ASX:CSL) share price is up 7.4% since the start of 2024. It’s probably worth asking, ‘is the CSL share price good value?’
The Pro Medicus Limited (ASX:PME) share price is up 57.3% since the start of 2024. It’s probably worth asking, ‘is the PME share price good value?’
The Pro Medicus Limited (ASX:PME) share price has jumped 55.7% since the start of 2024. It’s probably worth asking, ‘is the PME share price cheap?’
Strawman’s Andrew Page joins Owen Rask to talk results from Pro Medicus Ltd (ASX:PME), Commonwealth Bank of Australia (ASX:CBA) & Seek Ltd (ASX:SEK).
The Pro Medicus Ltd (ASX:PME) share price is up 8% after the ASX healthcare share announced a very strong FY24 result.
After falling 40%, is it possible that Audinate Ltd (ASX: AD8) shares are still overvalued? ASX Reporting Season special with Owen Rask and Seneca’s Luke Laretive and Ben Richards.
On the Australian Investors Podcast, Owen Rask and Drew Meredith, CFP take a look the market darlings Pro Medicus Ltd and NVIDIA Inc.
